✦ LIBER ✦

A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma

✍ Scribed by Wang-Gillam, Andrea; Plambeck-Suess, Stacey; Goedegebuure, Peter; Simon, Peter O.; Mitchem, Jonathan B.; Hornick, John R.; Sorscher, Steven; Picus, Joel; Suresh, Rama; Lockhart, Albert C.; Tan, Benjamin; Hawkins, Williams G.

Book ID: 121460244
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 174 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9866-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of imexon plus gemcitabi

A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

✍ Steven J. Cohen; Mark M. Zalupski; Manuel R. Modiano; Paul Conkling; Yehuda Z. P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 275 KB

PCA6: COST-EFFECTIVENESS OF GEMCITABINE

PCA6: COST-EFFECTIVENESS OF GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREATIC CANCER

✍ S Trippoli; A Messori 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Axitinib plus gemcitabine versus placebo

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

✍ Hedy L Kindler; Tatsuya Ioka; Dirk J Richel; Jaafar Bennouna; Richard Létourneau 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 226 KB

Phase II trial of vatalanib in patients

Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)

✍ Dragovich, T.; Laheru, D.; Dayyani, F.; Bolejack, V.; Smith, L.; Seng, J.; Burri 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 613 KB

A phase II randomized study of cetuximab

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

✍ Andrew H. Ko, Hagop Youssoufian, Jayne Gurtler, Karel Dicke, Omar Kayaleh, Heinz 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 177 KB

Phase I Study of Concomitant Gemcitabine

Phase I Study of Concomitant Gemcitabine and IMRT for Patients with Unresectable Adenocarcinoma of the Pancreatic Head

✍ Crane, Christopher H. ;Antolak, John A. ;Rosen, Isaac I. ;Forster, Kenneth M. ;E 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 266 KB